{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:34:52Z","timestamp":1787016892979,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research fund of Hanyang University","award":["HY- 202400000003922"],"award-info":[{"award-number":["HY- 202400000003922"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56572-9","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T20:12:38Z","timestamp":1780776758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low KIF4A expression is associated with gastric cancer progression and aggressive phenotypes"],"prefix":"10.1038","volume":"16","author":[{"given":"Seongsik","family":"Bang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoung Wan","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeseul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungyun","family":"Jee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosub","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Sam","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Gun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaekyung","family":"Myung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"56572_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"21834","author":"Bray","year":"2024","unstructured":"Bray, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 21834, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"56572_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"0","author":"AP Thrift","year":"2023","unstructured":"Thrift, A. P., Wenker, T. N. & El-Serag,. Global burden of gastric cancer: Epidemiological trends, risk factors, screening and prevention. Nat. Rev. Clin. Oncol. 0, 338\u2013349. https:\/\/doi.org\/10.1038\/s41571-023-00747-0 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"56572_CR3","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/S2468-1253(18)30237-1","volume":"3","author":"PC Lott","year":"2018","unstructured":"Lott, P. C. & Carvajal-Carmona, L. G. Resolving gastric cancer aetiology: An update in genetic predisposition. Lancet Gastroenterol. Hepatol. 3, 874\u2013883. https:\/\/doi.org\/10.1016\/S2468-1253(18)30237-1 (2018).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"56572_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren, P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 64, 31\u201349. https:\/\/doi.org\/10.1111\/apm.1965.64.1.31 (1965).","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"56572_CR5","unstructured":"Carneiro, F., Fukayama, M., Yasui, W. & Grabsch, H. I. in Digestive system tumours WHO classification of tumours (eds Rugge, M. & WHO classification of tumours editorial board) 82\u2013101 (International agency for research on cancer, 2019)."},{"key":"56572_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202\u2013209. https:\/\/doi.org\/10.1038\/nature13480 (2014).","journal-title":"Nature"},{"key":"56572_CR7","doi-asserted-by":"publisher","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer 26, 1\u201325, https:\/\/doi.org\/10.1007\/s10120-022-01331-8 (2023).","DOI":"10.1007\/s10120-022-01331-8"},{"key":"56572_CR8","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0140-6736(23)02033-0","volume":"402","author":"YY Janjigian","year":"2023","unstructured":"Janjigian, Y. Y. et al. Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: Interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial. Lancet 402, 2197\u20132208. https:\/\/doi.org\/10.1016\/S0140-6736(23)02033-0 (2023).","journal-title":"Lancet"},{"key":"56572_CR9","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/s41591-023-02465-7","volume":"29","author":"MA Shah","year":"2023","unstructured":"Shah, M. A. et al. Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial. Nat. Med. 29, 2133\u20132141. https:\/\/doi.org\/10.1038\/s41591-023-02465-7 (2023).","journal-title":"Nat. Med."},{"key":"56572_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41420-025-02771-8","volume":"11","author":"Y Zhu","year":"2025","unstructured":"Zhu, Y. et al. Targeting GPX2 to disrupt lipid homeostasis and enhance cisplatin sensitivity in diffuse gastric cancer. Cell Death Discov. 11, 491. https:\/\/doi.org\/10.1038\/s41420-025-02771-8 (2025).","journal-title":"Cell Death Discov."},{"key":"56572_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41420-026-03058-2","volume":"12","author":"P Laurenziello","year":"2026","unstructured":"Laurenziello, P. et al. Salinomycin as a death switch: How gastric cancer cells choose their demise. Cell Death Discov. 12, 3. https:\/\/doi.org\/10.1038\/s41420-026-03058-2 (2026).","journal-title":"Cell Death Discov."},{"key":"56572_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41420-025-02815-z","volume":"11","author":"Y Hu","year":"2025","unstructured":"Hu, Y. et al. Single-cell and spatial dissection of necroptosis spatiotemporal evolution driving lymph node metastasis in gastric cancer. Cell Death Discov. 11, 535. https:\/\/doi.org\/10.1038\/s41420-025-02815-z (2025).","journal-title":"Cell Death Discov."},{"key":"56572_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41420-025-02825-x","volume":"11","author":"L Zhou","year":"2025","unstructured":"Zhou, L., Wei, Y., Lin, K. & Lu, Y. L-tetrahydropalmatine synergizes cytotoxic CD8(+) T mediated antitumor and ferroptosis in gastric cancer. Cell Death Discov. 11, 541. https:\/\/doi.org\/10.1038\/s41420-025-02825-x (2025).","journal-title":"Cell Death Discov."},{"key":"56572_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41420-025-02850-w","volume":"12","author":"L Zhang","year":"2025","unstructured":"Zhang, L. et al. Effect of OASL on oxaliplatin-induced immunogenic cell death in gastric cancer via the cGAS-STING signaling pathway. Cell Death Discov. 12, 20. https:\/\/doi.org\/10.1038\/s41420-025-02850-w (2025).","journal-title":"Cell Death Discov."},{"key":"56572_CR15","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41420-025-02811-3","volume":"11","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Hypomethylation-mediated upregulation of PHOX1 promotes gastric cancer progression via transactivation of NGFR. Cell Death Discov. 11, 548. https:\/\/doi.org\/10.1038\/s41420-025-02811-3 (2025).","journal-title":"Cell Death Discov."},{"key":"56572_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1083\/jcb.200401142","volume":"166","author":"M Mazumdar","year":"2004","unstructured":"Mazumdar, M., Sundareshan, S. & Misteli, T. Human chromokinesin KIF4A functions in chromosome condensation and segregation. J. Cell Biol. 166, 613\u2013620. https:\/\/doi.org\/10.1083\/jcb.200401142 (2004).","journal-title":"J. Cell Biol."},{"key":"56572_CR17","doi-asserted-by":"publisher","first-page":"623","DOI":"10.14336\/AD.2017.0901","volume":"9","author":"F Tang","year":"2018","unstructured":"Tang, F. et al. Involvement of KIF4A in spindle formation and chromosome segregation in mouse oocytes. Aging Dis. 9, 623\u2013633. https:\/\/doi.org\/10.14336\/AD.2017.0901 (2018).","journal-title":"Aging Dis."},{"key":"56572_CR18","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11455","volume":"9","author":"J Pan","year":"2021","unstructured":"Pan, J., Lei, X. & Mao, X. Identification of KIF4A as a pan-cancer diagnostic and prognostic biomarker via bioinformatics analysis and validation in osteosarcoma cell lines. PeerJ 9, e11455. https:\/\/doi.org\/10.7717\/peerj.11455 (2021).","journal-title":"PeerJ"},{"key":"56572_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.20517\/2394-4722.2024.99","volume":"11","author":"X Zhang","year":"2025","unstructured":"Zhang, X., Zhang, Y., Zheng, G. & Yang, R. Expression characteristics, immune signatures, and prognostic value of the KIF family members identified across cancers. J. Cancer Metastasis Treat. 11, 4. https:\/\/doi.org\/10.20517\/2394-4722.2024.99 (2025).","journal-title":"J. Cancer Metastasis Treat."},{"key":"56572_CR20","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1158\/1078-0432.CCR-07-1328","volume":"13","author":"M Taniwaki","year":"2007","unstructured":"Taniwaki, M. et al. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer. Clin. Cancer Res. 13, 6624\u20136631. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-1328 (2007).","journal-title":"Clin. Cancer Res."},{"key":"56572_CR21","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1038\/s41598-017-04176-9","volume":"7","author":"G Hou","year":"2017","unstructured":"Hou, G. et al. Upregulate KIF4A enhances proliferation, invasion of hepatocellular carcinoma and indicates poor prognosis across human cancer types. Sci. Rep. 7, 4148. https:\/\/doi.org\/10.1038\/s41598-017-04176-9 (2017).","journal-title":"Sci. Rep."},{"key":"56572_CR22","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.2147\/OTT.S164730","volume":"11","author":"D Xue","year":"2018","unstructured":"Xue, D. et al. An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer. OncoTargets Ther. 11, 4755\u20134768. https:\/\/doi.org\/10.2147\/OTT.S164730 (2018).","journal-title":"OncoTargets Ther."},{"key":"56572_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41419-018-0550-9","volume":"9","author":"P-F Hou","year":"2018","unstructured":"Hou, P.-F. et al. KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer. Cell Death Dis. 9, 477. https:\/\/doi.org\/10.1038\/s41419-018-0550-9 (2018).","journal-title":"Cell Death Dis."},{"key":"56572_CR24","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1007\/s10637-020-00961-y","volume":"38","author":"G Liu","year":"2020","unstructured":"Liu, G. et al. The kinesin motor protein KIF4A as a potential therapeutic target in renal cell carcinoma. Invest. New Drugs 38, 1730\u20131742. https:\/\/doi.org\/10.1007\/s10637-020-00961-y (2020).","journal-title":"Invest. New Drugs"},{"key":"56572_CR25","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s11596-022-2636-y","volume":"42","author":"Wu","year":"2022","unstructured":"Wu, et al. Bioinformatic and experimental analyses reveal that KIF4A is a biomarker of therapeutic sensitivity and predicts prognosis in cervical cancer patients. Curr. Med. Sci. 42, 1273\u20131284. https:\/\/doi.org\/10.1007\/s11596-022-2636-y (2022).","journal-title":"Curr. Med. Sci."},{"key":"56572_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13277-010-0090-0","volume":"0","author":"Gao","year":"2011","unstructured":"Gao, et al. Overexpression of chromokinesin KIF4 inhibits proliferation of human gastric carcinoma cells both in vitro and in vivo. Tumour Biol. 0, 53\u201361. https:\/\/doi.org\/10.1007\/s13277-010-0090-0 (2011).","journal-title":"Tumour Biol."},{"key":"56572_CR27","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"Kim","year":"2018","unstructured":"Kim, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat. Med. 24, 1449\u20131458. https:\/\/doi.org\/10.1038\/s41591-018-0101-z (2018).","journal-title":"Nat. Med."},{"key":"56572_CR28","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"1","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 1, 1550\u20131558. https:\/\/doi.org\/10.1038\/s41591-018-0136-1 (2018).","journal-title":"Nat. Med."},{"key":"56572_CR29","doi-asserted-by":"publisher","first-page":"1902880","DOI":"10.1002\/advs.201902880","volume":"7","author":"YR Miao","year":"2020","unstructured":"Miao, Y. R. et al. ImmuCellAI: A unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy. Adv. Sci. 7, 1902880. https:\/\/doi.org\/10.1002\/advs.201902880 (2020).","journal-title":"Adv. Sci."},{"key":"56572_CR30","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.7150\/jca.77238","volume":"77238","author":"H Zhang","year":"2022","unstructured":"Zhang, H. et al. KIF4A drives gliomas growth by transcriptional repression of Rac1\/Cdc42 to induce cytoskeletal remodeling in glioma cells. J. Cancer 77238, 3640\u20133651. https:\/\/doi.org\/10.7150\/jca.77238 (2022).","journal-title":"J. Cancer"},{"key":"56572_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235523","volume":"15","author":"Y-J Kahm","year":"2023","unstructured":"Kahm, Y.-J., Kim, I.-G., Jung, U., Lee, J. H. & Kim, R.-K. Impact of KIF4A on cancer stem cells and EMT in lung cancer and glioma. Cancers 15, 5523. https:\/\/doi.org\/10.3390\/cancers15235523 (2023).","journal-title":"Cancers"},{"key":"56572_CR32","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12155","volume":"12155","author":"W Jin","year":"2021","unstructured":"Jin, W. & Ye, L. KIF4A knockdown suppresses ovarian cancer cell proliferation and induces apoptosis by downregulating BUB1 expression. Mol. Med. Rep. 12155, 516. https:\/\/doi.org\/10.3892\/mmr.2021.12155 (2021).","journal-title":"Mol. Med. Rep."},{"key":"56572_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02536-3","volume":"3","author":"Z Wang","year":"2025","unstructured":"Wang, Z. et al. RGS3 acts as a tumor promoter by facilitating the regulation of the TGF-\u03b2 signaling pathway and promoting EMT in ovarian cancer. Cell Death Discov. 3, 262. https:\/\/doi.org\/10.1038\/s41420-025-02536-3 (2025).","journal-title":"Cell Death Discov."},{"key":"56572_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11010-024-04943-z","volume":"480","author":"Y Xu","year":"2025","unstructured":"Xu, Y. et al. KIF4A promotes epithelial\u2013mesenchymal transition by activating the TGF-\u03b2\/SMAD signaling pathway in glioma cells. Mol. Cell. Biochem. 480, 217\u2013230. https:\/\/doi.org\/10.1007\/s11010-024-04943-z (2025).","journal-title":"Mol. Cell. Biochem."},{"key":"56572_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02503-y","volume":"11","author":"DM Xu","year":"2025","unstructured":"Xu, D. M. et al. Decoding the impact of MMP1+ malignant subsets on tumor-immune interactions: Insights from single-cell and spatial transcriptomics. Cell Death Discov. 11, 244. https:\/\/doi.org\/10.1038\/s41420-025-02503-y (2025).","journal-title":"Cell Death Discov."},{"key":"56572_CR36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12967-025-06526-y","volume":"23","author":"Z Hao","year":"2025","unstructured":"Hao, Z. et al. Invadopodia in cancer metastasis: Dynamics, regulation, and targeted therapies. J. Transl. Med. 23, 548. https:\/\/doi.org\/10.1186\/s12967-025-06526-y (2025).","journal-title":"J. Transl. Med."},{"key":"56572_CR37","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12967-025-06328-2","volume":"23","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Understanding pre-metastatic niche formation: Implications for colorectal cancer liver metastasis. J. Transl. Med. 23, 340. https:\/\/doi.org\/10.1186\/s12967-025-06328-2 (2025).","journal-title":"J. Transl. Med."},{"key":"56572_CR38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/imm.70038","volume":"177","author":"B Cai","year":"2026","unstructured":"Cai, B. et al. 5-FU resistance facilitates immune evasion in esophageal squamous cell carcinoma through ADAM10-mediated PD-L1 shedding and tumour microenvironment remodelling. Immunology 177, 170\u2013184. https:\/\/doi.org\/10.1111\/imm.70038 (2026).","journal-title":"Immunology"},{"key":"56572_CR39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/jso.21781","volume":"103","author":"YY Wang","year":"2011","unstructured":"Wang, Y. Y. et al. ADAM 10 is associated with gastric cancer progression and prognosis of patients. J. Surg. Oncol. 103, 116\u2013123. https:\/\/doi.org\/10.1002\/jso.21781 (2011).","journal-title":"J. Surg. Oncol."},{"key":"56572_CR40","doi-asserted-by":"publisher","first-page":"1170220","DOI":"10.3389\/fonc.2023.1170220","volume":"13","author":"J Ruan","year":"2023","unstructured":"Ruan, J. et al. The predictive role of soluble programmed death ligand 1 in digestive system cancers. Front. Oncol. 13, 1170220. https:\/\/doi.org\/10.3389\/fonc.2023.1170220 (2023).","journal-title":"Front. Oncol."},{"key":"56572_CR41","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12967-025-06279-8","volume":"23","author":"T Jiang","year":"2025","unstructured":"Jiang, T. et al. MCT4: A key player influencing gastric cancer metastasis and participating in the regulation of the metastatic immune microenvironment. J. Transl. Med. 23, 276. https:\/\/doi.org\/10.1186\/s12967-025-06279-8 (2025).","journal-title":"J. Transl. Med."},{"key":"56572_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153954","volume":"236","author":"S Zheng","year":"2022","unstructured":"Zheng, S. et al. Tumor-infiltrating lymphocyte signature in epithelial and stromal compartments of an esophageal squamous cell carcinoma acidic microenvironment mediated by MCT4. Pathol. Res. Pract. 236, 153954. https:\/\/doi.org\/10.1016\/j.prp.2022.153954 (2022).","journal-title":"Pathol. Res. Pract."},{"key":"56572_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/jpi.jpi_82_18","volume":"10","author":"F Aeffner","year":"2019","unstructured":"Aeffner, F. et al. Introduction to digital image analysis in whole-slide imaging: A white paper from the digital pathology association. J. Pathol. Inform. 10, 9. https:\/\/doi.org\/10.4103\/jpi.jpi_82_18 (2019).","journal-title":"J. Pathol. Inform."},{"key":"56572_CR44","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/modpathol.2016.34","volume":"29","author":"G St\u00e5lhammar","year":"2016","unstructured":"St\u00e5lhammar, G. et al. Digital image analysis outperforms manual biomarker assessment in breast cancer. Mod. Pathol. 29, 318\u2013329. https:\/\/doi.org\/10.1038\/modpathol.2016.34 (2016).","journal-title":"Mod. Pathol."},{"key":"56572_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1746-1596-7-27","volume":"7","author":"A Laurinavicius","year":"2012","unstructured":"Laurinavicius, A. et al. Immunohistochemistry profiles of breast ductal carcinoma: Factor analysis of digital image analysis data. Diagn. Pathol. 7, 27. https:\/\/doi.org\/10.1186\/1746-1596-7-27 (2012).","journal-title":"Diagn. Pathol."},{"key":"56572_CR46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1369\/00221554251335698","volume":"73","author":"H Horbas","year":"2025","unstructured":"Horbas, H. et al. Comparison of manual versus QuPath software\u2013based immunohistochemical scoring using oral squamous cell carcinoma as a model. J. Histochem. Cytochem. 73, 181\u2013196. https:\/\/doi.org\/10.1369\/00221554251335698 (2025).","journal-title":"J. Histochem. Cytochem."},{"key":"56572_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41374-018-0123-7","volume":"7","author":"B Acs","year":"2019","unstructured":"Acs, B. et al. Ki67 reproducibility using digital image analysis: An inter-platform and inter-operator study. Lab. Invest. 7, 107\u2013117. https:\/\/doi.org\/10.1038\/s41374-018-0123-7 (2019).","journal-title":"Lab. Invest."},{"key":"56572_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpi.2022.100118","volume":"100118","author":"GM Baker","year":"2022","unstructured":"Baker, G. M. et al. Immunohistochemistry scoring of breast tumor tissue microarrays: A comparison study across three software applications. J. Pathol. Inform. 100118, 100118. https:\/\/doi.org\/10.1016\/j.jpi.2022.100118 (2022).","journal-title":"J. Pathol. Inform."},{"key":"56572_CR49","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/path.5921","volume":"5921","author":"P Bankhead","year":"2022","unstructured":"Bankhead, P. Developing image analysis methods for digital pathology. J. Pathol. 5921, 391\u2013402. https:\/\/doi.org\/10.1002\/path.5921 (2022).","journal-title":"J. Pathol."},{"key":"56572_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"5","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 5, 16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5 (2017).","journal-title":"Sci. Rep."},{"key":"56572_CR51","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/bimj.200410135","volume":"47","author":"R Fluss","year":"2005","unstructured":"Fluss, R., Faraggi, D. & Reiser, B. Estimation of the Youden Index and its associated cutoff point. Biom. J. 47, 458\u2013472. https:\/\/doi.org\/10.1002\/bimj.200410135 (2005).","journal-title":"Biom. J."},{"key":"56572_CR52","doi-asserted-by":"publisher","first-page":"e27633","DOI":"10.2196\/27633","volume":"23","author":"A L\u00e1nczky","year":"2021","unstructured":"L\u00e1nczky, A. & Gy\u0151rffy, B. Web-based survival analysis tool tailored for medical research (KMplot): Development and implementation. J. Med. Internet Res. 23, e27633. https:\/\/doi.org\/10.2196\/27633 (2021).","journal-title":"J. Med. Internet Res."},{"key":"56572_CR53","doi-asserted-by":"publisher","first-page":"49322","DOI":"10.18632\/oncotarget.10337","volume":"10337","author":"AM Sz\u00e1sz","year":"2016","unstructured":"Sz\u00e1sz, A. M. et al. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget 10337, 49322\u201349333. https:\/\/doi.org\/10.18632\/oncotarget.10337 (2016).","journal-title":"Oncotarget"},{"key":"56572_CR54","doi-asserted-by":"publisher","first-page":"W415","DOI":"10.1093\/nar\/gkae456","volume":"52","author":"JM Elizarraras","year":"2024","unstructured":"Elizarraras, J. M. et al. WebGestalt 2024: Faster gene set analysis and new support for metabolomics and multi-omics. Nucleic Acids Res. 52, W415\u2013W421. https:\/\/doi.org\/10.1093\/nar\/gkae456 (2024).","journal-title":"Nucleic Acids Res."},{"key":"56572_CR55","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004 (2015).","journal-title":"Cell Syst."},{"key":"56572_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"56572_CR57","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"56572_CR58","doi-asserted-by":"publisher","first-page":"W534","DOI":"10.1093\/nar\/gkaf388","volume":"53","author":"H Cui","year":"2025","unstructured":"Cui, H. et al. TIMER3: An enhanced resource for tumor immune analysis. Nucleic Acids Res. 53, W534\u2013W541. https:\/\/doi.org\/10.1093\/nar\/gkaf388 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56572-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56572-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56572-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:45:48Z","timestamp":1787013948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56572-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56572"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56572-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Hanyang University Hospital (IRB file No. HYUH 2019-04-032-001, approval date: 22 May 2019). The requirement for informed consent was waived.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25869"}}